A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study

<p>Abstract</p> <p>Background</p> <p>Cancer cachexia is a syndrome of progressive weight loss. Non-small cell lung cancer patients experience a high incidence of cachexia of 61%. Research into methods to combat cancer cachexia in various tumour sites has recently progre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Rogers Elaine S, MacLeod Roderick D, Stewart Joanna, Bird Stephen P, Keogh Justin WL
Format: Artigo
Sprog:Inglês
Udgivet: BMC 2011-11-01
Serier:BMC Cancer
Online adgang:http://www.biomedcentral.com/1471-2407/11/493
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker